Dt. Nie et al., INHIBITION OF TERMINAL DIFFERENTIATION AND MATRIX CALCIFICATION IN CULTURED AVIAN GROWTH-PLATE CHONDROCYTES BY ROUS-SARCOMA VIRUS TRANSFORMATION, Journal of cellular biochemistry, 69(4), 1998, pp. 453-462
Endochondral bone formation involves the progression of epiphyseal gro
wth plate chondrocytes through a sequence of developmental stages whic
h include proliferation, differentiation, hypertrophy, and matrix calc
ification. To study this highly coordinated process, we infected growt
h plate chondrocytes with Rous sarcoma virus (RSV) and studied the eff
ects of RSV transformation on cell proliferation, differentiation, mat
rix synthesis, and mineralization. The RSV-transformed chondrocytes ex
hibited a distinct bipolar, fibroblast-like morphology, while the mock
-infected chondrocytes had a typical polygonal morphology. The RSV-tra
nsformed chondrocytes actively synthesized extracellular matrix protei
ns consisting mainly of type I collagen and fibronectin. RSV-transform
ed cells produced much less type X collagen than was produced by mock-
transformed cells. There also was a significant reduction of proteogly
can levels secreted in both the cell-matrix layer and culture media fr
om RSV-transformed chondrocytes. RSV-transformed chondrocytes expresse
d two-to-threefold more matrix metalloproteinase, while expressing onl
y one-half to one-third of the alkaline phosphatase activity of mock i
nfected cells. Finally, RSV-transformed chondrocytes failed to calcify
the extracellular matrix, while mock-transformed cells deposited high
levels of calcium and phosphate into their extracellular matrix. Thes
e results collectively indicate that RSV transformation disrupts the p
reprogrammed differentiation pattern of growth plate chondrocytes and
inhibit chondrocyte terminal differentiation and mineralization. They
also suggest that the expression of extracellular matrix proteins, typ
e II and type X collagens, and the cartilage proteoglycans are importa
nt for chondrocyte terminal differentiation and matrix calcification.
(C) 1998 Wiley-Liss, Inc.